Different investigations have shown that PD-L1 expression is not equal in all cancer cell groups, for example, in head and neck, lung, and breast cancer PD-L1 expression is mainly associated with CD44+ cells, a marker closely associated with GCSCs [65]. This evidence concerns the gene CD274 and breast carcinoma.